Glaxosmithkline PLC, 10% Owner at BICYCLE THERAPEUTICS plc (BCYC), sold 7,813 shares at $19.40 ($151K) on 2020-07-15, disclosed to the SEC on 2020-09-18.
Open-market sale of $151k BCYC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.27 | 1,597 | $31K | 20.3% |
| 2 | $19.25 | 78 | $2K | 1.0% |
| 3 | $19.40 | 3,069 | $60K | 39.3% |
| 4 | $19.40 | 3,069 | $60K | 39.3% |
| Total | $19.37 avg | 7,813 | $151K | 100% |
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |
| PAND | BUY | 2020-07-22 | $6.5M | — | Filing → |